BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12793338)

  • 1. Ecteinascidin-743.
    Held-Warmkessel J
    Clin J Oncol Nurs; 2003; 7(3):313-9. PubMed ID: 12793338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and cytotoxic evaluation of some cribrostatin-ecteinascidin analogues.
    Wright BJ; Chan C; Danishefsky SJ
    J Nat Prod; 2008 Mar; 71(3):409-14. PubMed ID: 18278868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA sequence- and structure-selective alkylation of guanine N2 in the DNA minor groove by ecteinascidin 743, a potent antitumor compound from the Caribbean tunicate Ecteinascidia turbinata.
    Pommier Y; Kohlhagen G; Bailly C; Waring M; Mazumder A; Kohn KW
    Biochemistry; 1996 Oct; 35(41):13303-9. PubMed ID: 8873596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ecteinascidin 743: a novel anticancer drug with a unique mechanism of action.
    Aune GJ; Furuta T; Pommier Y
    Anticancer Drugs; 2002 Jul; 13(6):545-55. PubMed ID: 12172500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ecteinascidin-743 (ET-743): early test or effective treatment in soft tissue sarcomas?
    Verweij J
    J Clin Oncol; 2005 Aug; 23(24):5420-3. PubMed ID: 16109999
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ecteinascidin 743].
    Lansiaux A; Bailly C
    Bull Cancer; 1999 Feb; 86(2):139-41. PubMed ID: 10094523
    [No Abstract]   [Full Text] [Related]  

  • 7. The inefficiency of incisions of ecteinascidin 743-DNA adducts by the UvrABC nuclease and the unique structural feature of the DNA adducts can be used to explain the repair-dependent toxicities of this antitumor agent.
    Zewail-Foote M; Li VS; Kohn H; Bearss D; Guzman M; Hurley LH
    Chem Biol; 2001 Nov; 8(11):1033-49. PubMed ID: 11731295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of the novel marine-derived anticancer agent ecteinascidin 743 in a phase I dose-finding study.
    van Kesteren C; Cvitkovic E; Taamma A; López-Lázaro L; Jimeno JM; Guzman C; Math t RA; Schellens JH; Misset JL; Brain E; Hillebrand MJ; Rosing H; Beijnen JH
    Clin Cancer Res; 2000 Dec; 6(12):4725-32. PubMed ID: 11156226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trabectedin: ET 743, ecteinascidin 743, Yondelis.
    Drugs R D; 2003; 4(1):75-81. PubMed ID: 12568645
    [No Abstract]   [Full Text] [Related]  

  • 10. Ecteinascidin 743: a minor groove alkylator that bends DNA toward the major groove.
    Zewail-Foote M; Hurley LH
    J Med Chem; 1999 Jul; 42(14):2493-7. PubMed ID: 10411470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New drugs from the sea.
    D'Incalci M; Simone M; Tavecchio M; Damia G; Garbi A; Erba E
    J Chemother; 2004 Nov; 16 Suppl 4():86-9. PubMed ID: 15688619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical and clinical results with the natural marine product ET-743.
    D'Incalci M; Jimeno J
    Expert Opin Investig Drugs; 2003 Nov; 12(11):1843-53. PubMed ID: 14585059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poisoning of human DNA topoisomerase I by ecteinascidin 743, an anticancer drug that selectively alkylates DNA in the minor groove.
    Takebayashi Y; Pourquier P; Yoshida A; Kohlhagen G; Pommier Y
    Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7196-201. PubMed ID: 10377391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ET-743 (PharmaMar/NCI/Ortho Biotech).
    Verschraegen CF; Glover K
    Curr Opin Investig Drugs; 2001 Nov; 2(11):1631-8. PubMed ID: 11763168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enantioselective synthesis of saframycin A and evaluation of antitumor activity relative to ecteinascidin/saframycin hybrids.
    Martinez EJ; Corey EJ
    Org Lett; 1999 Jul; 1(1):75-7. PubMed ID: 10822537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ET-743.
    Cvetkovic RS; Figgitt DP; Plosker GL
    Drugs; 2002; 62(8):1185-92; discussion 1193-4. PubMed ID: 12010079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potent anticancer compound ecteinascidin-743 (ET-743) as its 2-propanol disolvate.
    Sainz-Diaz CI; Manzanares I; Francesch A; Garcia-Ruiz J
    Acta Crystallogr C; 2003 Apr; 59(Pt 4):O197-8. PubMed ID: 12682407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antitumor activity of the novel marine agent, ecteinascidin-743 (ET-743, NSC-648766) against human tumors explanted from patients.
    Izbicka E; Lawrence R; Raymond E; Eckhardt G; Faircloth G; Jimeno J; Clark G; Von Hoff DD
    Ann Oncol; 1998 Sep; 9(9):981-7. PubMed ID: 9818072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of ecteinascidin ET-743 and phthalascidin Pt-650 from cyanosafracin B.
    Cuevas C; Pérez M; Martín MJ; Chicharro JL; Fernández-Rivas C; Flores M; Francesch A; Gallego P; Zarzuelo M; de La Calle F; García J; Polanco C; Rodríguez I; Manzanares I
    Org Lett; 2000 Aug; 2(16):2545-8. PubMed ID: 10956543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress in the studies on antitumor natural product ecteinascidin-743].
    Wang Y; Liu ZZ; Chen SZ; Liang XT
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):474-8. PubMed ID: 15379280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.